Cisapride (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cisapride" in English language version.

refsWebsite

Global rank English rank

4nih.gov

4^th place

3doi.org

2^nd place

2web.archive.org

1^st place

1in.gov.br

3,151^st place

5,932^nd place

1medicinenet.com

3,840^th place

3,358^th place

1latimes.com

22^nd place

19^th place

1espacenet.com

800^th place

676^th place

1lshtm.ac.uk

low place

1medscape.com

719^th place

636^th place

1cdsco.nic.in

low place

1semanticscholar.org

11^th place

8^th place

cdsco.nic.in

"Drugs banned in India". Central Drugs Standard Control Organization, Dte.GHS, Ministry of Health and Family Welfare, Government of India. Archived from the original on 2015-02-21. Retrieved 2013-09-17.

doi.org

Maclennan S, Augood C, Cash-Gibson L, Logan S, Gilbert RE (April 2010). "Cisapride treatment for gastro-oesophageal reflux in children" (PDF). The Cochrane Database of Systematic Reviews. 2010 (4): CD002300. doi:10.1002/14651858.CD002300.pub2. PMC 7138252. PMID 20393933.
Aboumarzouk OM, Agarwal T, Antakia R, Shariff U, Nelson RL (January 2011). "Cisapride for intestinal constipation". The Cochrane Database of Systematic Reviews (1): CD007780. doi:10.1002/14651858.CD007780.pub2. PMID 21249695.
Hedner T, Hedner J, Gelin-Friberg A, Huang ML, Van de Poel S, Woestenborghs R, Van Peer A, Heykants J (1990). "Comparative bioavailability of a cisapride suppository and tablet formulation in healthy volunteers". European Journal of Clinical Pharmacology. 38 (6): 629–31. doi:10.1007/bf00278595. PMID 2373139. S2CID 33641651.

espacenet.com

worldwide.espacenet.com

US patent 5955478, Gray NM, Young JW, "Methods for treating gastrointestinal motility dysfunction using optically pre (+) cisapride", issued 1999-Sep-21

in.gov.br

Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.

latimes.com

"PROPULSID: A Heartburn Drug, Now Linked to Children's Deaths". Los Angeles Times. 2000-12-20. Retrieved 2021-12-25.

lshtm.ac.uk

researchonline.lshtm.ac.uk

Maclennan S, Augood C, Cash-Gibson L, Logan S, Gilbert RE (April 2010). "Cisapride treatment for gastro-oesophageal reflux in children" (PDF). The Cochrane Database of Systematic Reviews. 2010 (4): CD002300. doi:10.1002/14651858.CD002300.pub2. PMC 7138252. PMID 20393933.

medicinenet.com

"Propulsid To Go Off Market - Warning". MedicineNet. Retrieved 2021-12-25.

medscape.com

""Cardiac contraindications included in new FDA warnings about Propulsid"". medscape.com. January 25, 2000. Retrieved 10 May 2021.

nih.gov

pubmed.ncbi.nlm.nih.gov

Maclennan S, Augood C, Cash-Gibson L, Logan S, Gilbert RE (April 2010). "Cisapride treatment for gastro-oesophageal reflux in children" (PDF). The Cochrane Database of Systematic Reviews. 2010 (4): CD002300. doi:10.1002/14651858.CD002300.pub2. PMC 7138252. PMID 20393933.
Aboumarzouk OM, Agarwal T, Antakia R, Shariff U, Nelson RL (January 2011). "Cisapride for intestinal constipation". The Cochrane Database of Systematic Reviews (1): CD007780. doi:10.1002/14651858.CD007780.pub2. PMID 21249695.
Hedner T, Hedner J, Gelin-Friberg A, Huang ML, Van de Poel S, Woestenborghs R, Van Peer A, Heykants J (1990). "Comparative bioavailability of a cisapride suppository and tablet formulation in healthy volunteers". European Journal of Clinical Pharmacology. 38 (6): 629–31. doi:10.1007/bf00278595. PMID 2373139. S2CID 33641651.

ncbi.nlm.nih.gov

Maclennan S, Augood C, Cash-Gibson L, Logan S, Gilbert RE (April 2010). "Cisapride treatment for gastro-oesophageal reflux in children" (PDF). The Cochrane Database of Systematic Reviews. 2010 (4): CD002300. doi:10.1002/14651858.CD002300.pub2. PMC 7138252. PMID 20393933.

semanticscholar.org

api.semanticscholar.org

Hedner T, Hedner J, Gelin-Friberg A, Huang ML, Van de Poel S, Woestenborghs R, Van Peer A, Heykants J (1990). "Comparative bioavailability of a cisapride suppository and tablet formulation in healthy volunteers". European Journal of Clinical Pharmacology. 38 (6): 629–31. doi:10.1007/bf00278595. PMID 2373139. S2CID 33641651.

web.archive.org

Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
"Drugs banned in India". Central Drugs Standard Control Organization, Dte.GHS, Ministry of Health and Family Welfare, Government of India. Archived from the original on 2015-02-21. Retrieved 2013-09-17.